微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[20] 发布: 2013/08/28 15:23:09
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
已读[20] 发布: 2013/08/27 15:24:16
Family Practice News Digital Network The cardiac safety of rosiglitazone, a thiazolidinedione (TZD) marketed as Avandia by GlaxoSmithKline, has been mired in controversy for several years because of analyses of data showing that rosiglitazone may increase the risk of MI or death. The Food  ...
已读[21] 发布: 2013/08/27 15:23:51
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
已读[21] 发布: 2013/08/26 15:27:53
在使用噻唑烷二酮类药物之前应检查肝功能并在使用过程中注意肝功能的监测。如果您有活动性肝病或转氨酶增高超过正常上限2.5倍的病友应禁用该类药物。该药服用...
已读[21] 发布: 2013/08/26 15:27:44
目前首选胰岛素增敏剂来治疗胰岛素抵抗,而胰岛素增敏剂主要是噻唑烷二酮类药物,如罗格列酮、吡格列酮等,尤其对后天肥胖的糖尿病患者疗效较为显著。 如果是以...
已读[204] 发布: 2013/08/26 15:26:16
博士对1999-2001年期间开始糖尿病治疗的14891例55岁及以上的2型糖尿病患者队列进行研究,研究仅纳入开始单一药物治疗[二甲双胍、磺酰脲类药物、噻唑烷二酮类药物(...
已读[20] 发布: 2013/08/26 15:26:00
Family Practice News Digital Network The cardiac safety of rosiglitazone, a thiazolidinedione (TZD) marketed as Avandia by GlaxoSmithKline, has been mired in controversy for several years because of analyses of data showing that rosiglitazone may increase the risk of MI or death. The Food  ...
已读[21] 发布: 2013/08/26 15:25:32
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
已读[31] 发布: 2013/08/25 15:23:09
Family Practice News Digital Network The cardiac safety of rosiglitazone, a thiazolidinedione (TZD) marketed as Avandia by GlaxoSmithKline, has been mired in controversy for several years because of analyses of data showing that rosiglitazone may increase the risk of MI or death. The Food  ...
已读[32] 发布: 2013/08/25 15:22:42
Clinical Endocrinology News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ...
« 上一页  |   查看结果341-350共483   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘